Home Photos Surgery Types Cosmetic Surgeons Surgery Prices Surgery Risks Plastic Surgery News

Hollis-Eden Pharmaceuticals Announces Filing of IND for Phase I/II Clinical Trials with HE3286 in Diseases of … (Business Wire via Yahoo! Finance)

SAN DIEGO—-Hollis-Eden Pharmaceuticals, Inc. announced today that it has filed an Investigational New Drug application with the U.S. Food and Drug Administration to begin clinical trials with its drug candidate HE3286 for the treatment of diseases of inflammation.

More: continued here





You can respond, or trackback from your own site.


Related News

  • Arena Pharmaceuticals begins arterial thrombosis drug trial (PharmaBiz)
  • FDA Approves CustomVue Monovision LASIK (U. S. Food and Drug Administration)
  • Alcon Gets FDA Nod For Triesence Drug Forbes
  • Allergan drug gets label extension (bizjournals.com via Yahoo! Finance)
  • Sanofi pulls obesity drug application in U.S. (Reuters)
  • STAAR Surgical Submits Application to FDA for the Visian Toric ICL
  • Allergan Announces FDA Approval of Label Extensions for JUVEDERM(TM) Ultra and JUVEDERM(TM) Ultra Plus (Business Wire via Yahoo! Finance)
  • Akorn Files New Drug Application With FDA For Topical Ocular OSN SuperSite Subscription
  • Guilty plea on Botox could put doctor in jail (Albuquerque Tribune)
  • ReGen Biologics Receives NSE Letter from FDA, Proceeding with Next Steps to Gain U.S. Market Clearance (Business Wire via Yahoo! Finance)


    • Leave a Reply
    Cosmetic Surgery Procedure.com | Cosmetic Surgery Types | Find a Cosmetic Surgeon | Cosmetic Surgery Prices | Cosmetic Surgery Risks | Resources | Contact Us